Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial

Added 466 days ago (28.04.2021)
Authors: Kaspar Broch; Einar Gude; Kristjan Karason; Göran Dellgren; Göran Rådegran; Grunde Gjesdal; Finn Gustafsson; Hans Eiskjaer; Jyri Lommi; Markku Pentikäinen; Karl B Lemström; Arne K Andreassen; Lars Gullestad
Read article